Disease Markers · 2019 · 30 citations · 21 references
MedicineCardiologyInternal MedicineClinical CardiologyInflammationSurvival AnalysisCardiac BiomarkersCardiac Risk AssessmentCardiovascular DiseaseEndothelial DysfunctionHeart FailureSurvival OutcomesCardiac Outcome AssessmentHeart Failure BiomarkersHeart Failure Risk PredictionInflammatory Cardiac BiomarkersLow-grade Chronic InflammationPrognostic PredictionPrognostic VariablesVascular Endothelial Dysfunction
Background . Heart failure (HF) is characterized by unfavorable prognosis. Disease trajectory of HF, however, may vary, and risk assessment of patients remains elusive. In our study, we sought to determine the prognostic impact of endocan—a novel biomarker of endothelial dysfunction and low-grade inflammation—in patients with heart failure. Methods . In outpatients with chronic HF, baseline values of endocan were determined and clinical follow-up for a minimum of 18 months obtained. A multivariate Cox proportional hazard model was built for HF-related death or hospitalization requiring inotropic support. Results . A total of 120 patients (mean age 71 years, 64% male, mean LVEF 36%) were included. During a mean follow-up of <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mn>656</mml:mn><mml:mo>±</mml:mo><mml:mn>109</mml:mn></mml:math> days, 50 patients (41.6%) experienced an event. On Cox multivariate analysis, endocan values emerged as an independent predictor of HF prognosis (HR, 1.471 CI 95% 1.183-1.829, <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M2"><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.001</mml:mn></mml:math>, for each 1 ng/mL increase) even after adjustment for age, gender, HF etiology, LVEF, NYHA class, NT-proBNP, and exercise tolerance. Conclusions . Endocan is an independent predictor of HF-related events in chronic HF individuals and represents a promising tool for risk assessment of HF patients.
21
John G.F. Cleland, Andrew J.S. Coats, Ewa A. Jankowska et al. · PubMed · 2021 · 19.5K citations
Long-Term Trends in the Incidence of and Survival with Heart Failure
Daniel Levy, Satish Kenchaiah, Martin G. Larson et al. · New England Journal of Medicine · 2002 · 2.2K citations · Full text
Ovidiu Chioncel, Mitja Lainščak, Petar Seferović et al. · European Journal of Heart Failure · 2017 · 904 citations · Full text
Dieter Fischer, S. Della Rossa, Ulf Landmesser et al. · European Heart Journal · 2004 · 323 citations